254 related articles for article (PubMed ID: 23733769)
1. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.
Custódio G; Parise GA; Kiesel Filho N; Komechen H; Sabbaga CC; Rosati R; Grisa L; Parise IZ; Pianovski MA; Fiori CM; Ledesma JA; Barbosa JR; Figueiredo FR; Sade ER; Ibañez H; Arram SB; Stinghen ST; Mengarelli LR; Figueiredo MM; Carvalho DC; Avilla SG; Woiski TD; Poncio LC; Lima GF; Pontarolo R; Lalli E; Zhou Y; Zambetti GP; Ribeiro RC; Figueiredo BC
J Clin Oncol; 2013 Jul; 31(20):2619-26. PubMed ID: 23733769
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC
Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
[TBL] [Abstract][Full Text] [Related]
5. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors.
Feitosa JADS; das Chagas PF; de Sousa GR; Queiroz RGP; Cruzeiro GAV; Tone LG; Borges KS; Valera ET
Mol Biol Rep; 2020 Aug; 47(8):6439-6443. PubMed ID: 32671623
[TBL] [Abstract][Full Text] [Related]
6. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
7. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
Figueiredo BC; Sandrini R; Zambetti GP; Pereira RM; Cheng C; Liu W; Lacerda L; Pianovski MA; Michalkiewicz E; Jenkins J; Rodriguez-Galindo C; Mastellaro MJ; Vianna S; Watanabe F; Sandrini F; Arram SB; Boffetta P; Ribeiro RC
J Med Genet; 2006 Jan; 43(1):91-6. PubMed ID: 16033918
[TBL] [Abstract][Full Text] [Related]
8. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of adrenocortical tumors in southern Brazil.
Custódio G; Komechen H; Figueiredo FR; Fachin ND; Pianovski MA; Figueiredo BC
Mol Cell Endocrinol; 2012 Mar; 351(1):44-51. PubMed ID: 22056871
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.
Custodio G; Taques GR; Figueiredo BC; Gugelmin ES; Oliveira Figueiredo MM; Watanabe F; Pontarolo R; Lalli E; Torres LF
PLoS One; 2011 Mar; 6(3):e18015. PubMed ID: 21445348
[TBL] [Abstract][Full Text] [Related]
11. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
Varley JM; McGown G; Thorncroft M; James LA; Margison GP; Forster G; Evans DG; Harris M; Kelsey AM; Birch JM
Am J Hum Genet; 1999 Oct; 65(4):995-1006. PubMed ID: 10486318
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
[TBL] [Abstract][Full Text] [Related]
13. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
Assumpção JG; Seidinger AL; Mastellaro MJ; Ribeiro RC; Zambetti GP; Ganti R; Srivastava K; Shurtleff S; Pei D; Zeferino LC; Dufloth RM; Brandalise SR; Yunes JA
BMC Cancer; 2008 Dec; 8():357. PubMed ID: 19046423
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of Neuroblastoma among TP53 p.R337H Carriers.
Seidinger AL; Fortes FP; Mastellaro MJ; Cardinalli IA; Zambaldi LG; Aguiar SS; Yunes JA
PLoS One; 2015; 10(10):e0140356. PubMed ID: 26452166
[TBL] [Abstract][Full Text] [Related]
15. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
[TBL] [Abstract][Full Text] [Related]
16. Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
Achatz MI; Hainaut P; Ashton-Prolla P
Lancet Oncol; 2009 Sep; 10(9):920-5. PubMed ID: 19717094
[TBL] [Abstract][Full Text] [Related]
17. Penetrance of the
Costa TEJ; Gerber VKQ; Ibañez HC; Melanda VS; Parise IZS; Watanabe FM; Pianovski MAD; Fiori CMCM; Fabro ALMR; Silva DBD; Andrade DP; Komechen H; Mendes MC; Carboni E; Kuczynski AP; Souza EN; Paraizo MM; Ibañez MVC; Castilho LM; Cruz AF; Maia TFD; Machado-Souza C; Rosati R; Oliveira CS; Parise GA; Passos JDC; Barbosa JRS; Figueiredo MMO; Lima L; Tormen T; Sabbaga CC; Ávilla SGA; Grisa L; Aranha A; Tosin KCF; Ogradowski KRP; Lima G; Legal EF; Anegawa TH; Mazzuco TL; Grion AL; Balbinotti JHG; Dammski KL; Melo RG; Filho NK; Custódio G; Figueiredo BC
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31744167
[TBL] [Abstract][Full Text] [Related]
18. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
[TBL] [Abstract][Full Text] [Related]
19. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.
Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M
J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031
[TBL] [Abstract][Full Text] [Related]
20. TP53 p.Arg337His geographic distribution correlates with adrenocortical tumor occurrence.
Seidinger AL; Caminha IP; Mastellaro MJ; Gabetta CS; Nowill AE; Pinheiro VRP; Yunes JA
Mol Genet Genomic Med; 2020 Sep; 8(9):e1168. PubMed ID: 32592449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]